26 April 2018
Authored and Edited by Shrey Pathak, Ph.D.; Leythem A. Wall
On 26 April 2018, World Intellectual Property Day, the UK government announced that it has ratified the Unified Patent Court Agreement (UPCA). The UK therefore becomes the sixteenth state to do so, leaving Germany as the only remaining country required to ratify for the Unified Patent Court (UPC) and Unitary Patent system (UPS) to come into force.
The UK Intellectual Property Minister, Sam Gyimah MP is quoted as saying:
"Ratification of this important Agreement demonstrates that internationally, as well as at home, the UK is committed to strong intellectual property protections. This will help to foster innovation and creativity, bringing our modern and ambitious Industrial Strategy to life."
The UPCA is an international agreement between the majority of European Union member states to establish a new, centralized patent court in Europe (the UPC), which will eventually have sole court jurisdiction to decide on disputes arising from Unitary Patents and European patents in these member states.
While UK ratification represents a major development towards the UPC and UPS finally becoming a reality, the project remains on hold because of a pending complaint against the UPC filed with the German Federal Constitutional Court last year. This action currently prevents Germany from pushing ahead with their ratification, but the Constitutional Court has listed the complaint to be dealt with this year.
For further information, please contact your Finnegan attorney.
Copyright © 2018 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
At the PTAB Blog
Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a
§ 325(d) EPR Denial
May 28, 2026
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Webinar
Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement
May 18, 2026
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.